{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T06:48:01Z","timestamp":1794638881904,"version":"4.9.1"},"reference-count":36,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T00:00:00Z","timestamp":1588032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Systemic sclerosis (SSc) is the connective tissue disease with the highest mortality and patients with chronic inflammatory immune-mediated diseases are at high risk of acquiring infections as they are often treated with immunosuppressive or biological drugs. This study, conducted among the patients followed by our clinical immunology, part of the Internal Medicine Department in the Ospedale Policlinico San Martino, Genoa, northwest Italy, has set itself the primary objective of analyzing the vaccine uptake and the vaccination coverage against both seasonal influenza and S. pneumoniae in a cohort of patients with SSc. We evaluated the influenza and pneumococcal vaccination rate among various subgroups of patients and the source of the recommendation for vaccination. We evaluated the vaccination rate changes between the two years considered in our study. We also calculated a binomial logistic regression between vaccination acceptance and clinical and demographics characteristics of the patients to evaluate the adjusted odds ratio (OR) of each factor on vaccination. The vaccination coverage that resulted was significantly higher than in other similar studies. Age over 65 years old, interstitial lung disease, and ongoing immunosuppressive therapy were significantly related with acceptance to both vaccinations using univariate analyses, but the multivariate logistic regression found a significant correlation only with the age and therapy factors.<\/jats:p>","DOI":"10.3390\/vaccines8020204","type":"journal-article","created":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T09:57:21Z","timestamp":1588067841000},"page":"204","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Systemic Sclerosis and Vaccinations: A Register-Based Cohort Study about Seasonal Influenza and Streptococcus pneumoniae Vaccination Rate and Uptake from Liguria Regional Center, Northwest Italy"],"prefix":"10.3390","volume":"8","author":[{"given":"Giuseppe","family":"Murdaca","sequence":"first","affiliation":[{"name":"Departments of Internal Medicine, Scleroderma Unit, Clinical Immunology Unit, University of Genova, 16132 Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6827-6191","authenticated-orcid":false,"given":"Giovanni","family":"Noberasco","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Vaccines and Clinical Trials Unit, University of Genova, 16132 Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0593-0090","authenticated-orcid":false,"given":"Alberto","family":"Battaglini","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Vaccines and Clinical Trials Unit, University of Genova, 16132 Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Vassallo","sequence":"additional","affiliation":[{"name":"Departments of Internal Medicine, Scleroderma Unit, Clinical Immunology Unit, University of Genova, 16132 Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Giusti","sequence":"additional","affiliation":[{"name":"Departments of Internal Medicine, Scleroderma Unit, Clinical Immunology Unit, University of Genova, 16132 Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Greco","sequence":"additional","affiliation":[{"name":"Departments of Internal Medicine, Scleroderma Unit, Clinical Immunology Unit, University of Genova, 16132 Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Schiavi","sequence":"additional","affiliation":[{"name":"Departments of Internal Medicine, Scleroderma Unit, Clinical Immunology Unit, University of Genova, 16132 Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Sticchi","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Vaccines and Clinical Trials Unit, University of Genova, 16132 Genova, Italy"},{"name":"Hygiene Unit, \u201cOspedale Policlinico San Martino IRCCS\u201d, 16132 Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8463-8487","authenticated-orcid":false,"given":"Giancarlo","family":"Icardi","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Vaccines and Clinical Trials Unit, University of Genova, 16132 Genova, Italy"},{"name":"Hygiene Unit, \u201cOspedale Policlinico San Martino IRCCS\u201d, 16132 Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2433-9610","authenticated-orcid":false,"given":"Andrea","family":"Orsi","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Vaccines and Clinical Trials Unit, University of Genova, 16132 Genova, Italy"},{"name":"Hygiene Unit, \u201cOspedale Policlinico San Martino IRCCS\u201d, 16132 Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,4,28]]},"reference":[{"key":"ref_1","first-page":"1867","article-title":"Increased prevalence of scleroderma in southwestern Ontario: A cluster analysis","volume":"29","author":"Thompson","year":"2002","journal-title":"J. Rheumatol."},{"key":"ref_2","first-page":"501","article-title":"Outcome measurements in scleroderma: Results from a delphi exercise","volume":"34","author":"Gazi","year":"2007","journal-title":"J. Rheumatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: An American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"65","author":"Khanna","year":"2013","journal-title":"Arthritis Rheum"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/annrheumdis-2014-206386","article-title":"A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: A EUSTAR prospective study","volume":"75","author":"Elhai","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"A311","DOI":"10.1016\/j.autrev.2009.11.003","article-title":"Geoepidemiology of systemic sclerosis","volume":"9","author":"Ranque","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.semarthrit.2014.05.010","article-title":"Mortality and survival in systemic sclerosis: Systematic review and meta-analysis","volume":"44","author":"Royo","year":"2014","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1378\/chest.12-2396","article-title":"Systemic sclerosis-associated pulmonary arterial hypertension","volume":"144","author":"Chaisson","year":"2013","journal-title":"Chest"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.3899\/jrheum.141617","article-title":"Outcome of patients with systemic sclerosis in the intensive care unit","volume":"42","author":"Hissem","year":"2015","journal-title":"J. Rheumatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/BOR.0000000000000027","article-title":"Mortality in systemic sclerosis","volume":"26","author":"Nikpour","year":"2014","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.atherosclerosis.2012.05.013","article-title":"Endothelial dysfunction in rheumatic autoimmune diseases","volume":"224","author":"Murdaca","year":"2012","journal-title":"Atherosclerosis"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1196\/annals.1313.013","article-title":"Non-Antigen-Specific CD8+ T Suppressor Lymphocytes in Diseases Characterized by Chronic Immune Responses and Inflammation","volume":"1050","author":"Filaci","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Manetti, M., Pratesi, S., Romano, E., Bellando-Randone, S., Rosa, I., Guiducci, S., Fioretto, B.S., Ibba-Manneschi, L., Maggi, E., and Matucci-Cerinic, M. (2017). Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosis. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0183102"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Landemaine, A., Petitcollin, A., Brochard, C., Miard, C., Dewitte, M., Le Balc\u2019H, E., Grainville, T., Bellissant, E., Siproudhis, L., and Bouguen, G. (2020). Cumulative exposure to infliximab, but not trough concentrations, correlate with rate of infection. Clin. Gastroenterol. Hepatol.","DOI":"10.1016\/j.cgh.2020.03.018"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1517\/14740338.2015.1009036","article-title":"Infection risk associated with anti-TNF-\u03b1 agents: A review","volume":"14","author":"Murdaca","year":"2015","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1517\/14740338.2014.899579","article-title":"Efficacy and safety of etanercept in chronic immune-mediated disease","volume":"13","author":"Murdaca","year":"2014","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2147\/IBPC.S232038","article-title":"Management of pulmonary arterial hypertension in patients with systemic sclerosis","volume":"13","author":"Almaaitah","year":"2020","journal-title":"Integr. Blood Press. Control."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"rkz007","DOI":"10.1093\/rap\/rkz007","article-title":"Eight-year survival study of first-line tumour necrosis factor \u03b1 inhibitors in rheumatoid arthritis: Real-world data from a university centre registry","volume":"3","author":"Papadopoulos","year":"2019","journal-title":"Rheumatol. Adv. Pract."},{"key":"ref_18","first-page":"1733","article-title":"Influenza","volume":"355","author":"Ghebrehewet","year":"2016","journal-title":"BMJ"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1086\/341403","article-title":"Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations","volume":"35","author":"Hak","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Blumentals, W.A., Arreglado, A., Napalkov, P., and Toovey, S. (2012). Rheumatoid arthritis and the incidence of influenza and influenza-related complications: A retrospective cohort study. BMC Musculoskelet. Disord., 13.","DOI":"10.1186\/1471-2474-13-158"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e001035","DOI":"10.1136\/rmdopen-2019-001035","article-title":"Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: A systematic literature review for the 2019 update of EULAR recommendations","volume":"5","author":"Rondaan","year":"2019","journal-title":"RMD Open"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"E629","DOI":"10.1111\/j.1399-0012.2011.01495.x","article-title":"Pneumonia in allogeneic stem cell transplantation recipients: A multicenter prospective study","volume":"25","author":"Espigado","year":"2011","journal-title":"Clin. Transpl."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.autrev.2013.07.007","article-title":"Influenza and pneumococcal vaccinations of patients with systemic lupus erythematosus: Current views upon safety and immunogenicity","volume":"13","author":"Murdaca","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1365-2796.2009.02149.x","article-title":"Vaccinate your child and save its grandparents from a heart attack? Current perspectives in antipneumococcal vaccination","volume":"266","year":"2009","journal-title":"J. Intern. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1086\/587063","article-title":"Vaccines: Vaccination in patients with chronic rheumatic or autoimmune diseases","volume":"46","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.autrev.2010.12.003","article-title":"Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: A systematic literature review for the European league against rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases","volume":"10","author":"Elkayam","year":"2011","journal-title":"Autoimmun. Rev."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.autrev.2011.10.015","article-title":"Vaccination of patients with auto-immune inflammatory rheumatic diseases requires careful benefit-risk assessment","volume":"11","author":"Bijl","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1086\/655828","article-title":"Association of serotype with risk of death due to pneumococcal pneumonia: A meta-analysis","volume":"51","author":"Weinberger","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Martens, P., Worm, S.W., Lundgren, B., Konradsen, H.B., and Benfield, T. (2004). Serotype-specific mortality from invasive Streptococcus pneumoniaedisease revisited. BMC Infect. Dis., 4.","DOI":"10.1186\/1471-2334-4-21"},{"key":"ref_30","unstructured":"(2019, March 19). Piano Nazionale Prevenzione Vaccinale; (PNPV) 2017\u20132019, Available online: www.salute.gov.it\/imgs\/C_17_pubblicazioni_2571_allegato.pdf."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.autrev.2017.09.010","article-title":"Humanistic and cost burden of systemic sclerosis: A review of the literature","volume":"16","author":"Fischer","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1016\/j.vaccine.2018.06.065","article-title":"Predictors for influenza vaccine acceptance among patients with inflammatory rheumatic diseases","volume":"36","author":"Harrison","year":"2018","journal-title":"Vaccine"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/rheumatology\/kep440","article-title":"Low influenza vaccination rate among patients with systemic sclerosis","volume":"49","author":"Mouthon","year":"2009","journal-title":"Rheumatology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s00296-016-3516-1","article-title":"Influenza and pneumococcal vaccination in patients with rheumatoid arthritis in comparison with age- and sex-matched controls: Results of a claims data analysis","volume":"36","author":"Ramos","year":"2016","journal-title":"Rheumatol. Int."},{"key":"ref_35","unstructured":"(2020, January 20). Available online: http:\/\/www.salute.gov.it\/portale\/influenza\/dettaglioOpuscoliInfluenza.jsp?lingua=italiano&id=356."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Costello, R.E., Winthrop, K.L., Pye, S., Brown, B., and Dixon, W.G. (2016). Influenza and pneumococcal vaccination uptake in patients with rheumatoid arthritis treated with immunosuppressive therapy in the UK: A retrospective cohort study using data from the clinical practice research datalink. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0153848"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/8\/2\/204\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:24:01Z","timestamp":1760361841000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/8\/2\/204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,28]]},"references-count":36,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,6]]}},"alternative-id":["vaccines8020204"],"URL":"https:\/\/doi.org\/10.3390\/vaccines8020204","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,28]]}}}